ARCHIVES

Bosutinib Vs. Imatinib Study Didn’t Meet Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

Administration Asking $233 Million Less For NCI In FY ’88 Than Congress Is Appropriating For ‘87

October 10, 1986

NCI Offers 200 Cell Lines to Scientist

May 6, 1983

ACS Plans To Review Prostate Cancer Screening Guideline

March 20, 2009

Rituxan Approved as Maintenance For Advanced Follicular Lymphoma

February 25, 2011

Brain Gliomas Progress When Gene Function Is Lost

April 25, 2003

Hypothyroidism Associated With Reduced Breast Cancer

April 25, 2003